GMFGRN: a matrix factorization and graph neural network approach for gene regulatory network inference
Briefings in Bioinformatics · 22.01.2024 · 25 (2)
DOI: 10.1093/bib/bbad529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 22.01.2024. Verfasst von Shuo Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Engineering, Nanjing University of Science and Technology, 200 Xiaolingwei, Nanjing, 210094, China. Hauptthemen laut MEDLINE: Gene Regulatory Networks. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu, Foundation of National Defense Key Laboratory of Science and Technology.
Abstract (Originalsprache)
The recent advances of single-cell RNA sequencing (scRNA-seq) have enabled reliable profiling of gene expression at the single-cell level, providing opportunities for accurate inference of gene regulatory networks (GRNs) on scRNA-seq data. Most methods for inferring GRNs suffer from the inability to eliminate transitive interactions or necessitate expensive computational resources. To address these, we present a novel method, termed GMFGRN, for accurate graph neural network (GNN)-based GRN inference from scRNA-seq data. GMFGRN employs GNN for matrix factorization and learns representative embeddings for genes. For transcription factor–gene pairs, it utilizes the learned embeddings to determine whether they interact with each other. The extensive suite of benchmarking experiments encompassing eight static scRNA-seq datasets alongside several state-of-the-art methods demonstrated mean improvements of 1.9 and 2.5% over the runner-up in area under the receiver operating characteristic curve (AUROC) and area under the precision–recall curve (AUPRC). In addition, across four time-series datasets, maximum enhancements of 2.4 and 1.3% in AUROC and AUPRC were observed in comparison to the runner-up. Moreover, GMFGRN requires significantly less training time and memory consumption, with time and memory consumed <10% compared to the second-best method. These findings underscore the substantial potential of GMFGRN in the inference of GRNs. It is publicly available at https://github.com/Lishuoyy/GMFGRN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Computer Science and Engineering, Nanjing University of Science and Technology, 200 Xiaolingwei, Nanjing, 210094, China.
- School of information Engineering, Yangzhou University, 196 West Huayang, Yangzhou, 225000, China.
- Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria 3800, Australia.
- Monash Data Futures Institute, Monash University, Melbourne, Victoria 3800, Australia.
ORCID-Profile: Yan Liu, Long-Chen Shen, Jiangning Song, Dong-Jun Yu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu
- Foundation of National Defense Key Laboratory of Science and Technology
- Major and Seed Inter-Disciplinary Research
- Monash University
Zitieren
APA
Li, S., Liu, Y., Shen, L. C., Yan, H., Song, J., & Yu, D. J. (2024). GMFGRN: a matrix factorization and graph neural network approach for gene regulatory network inference. Briefings in Bioinformatics, 25(2). https://doi.org/10.1093/bib/bbad529
Vancouver
Li S, Liu Y, Shen LC, Yan H, Song J, Yu DJ. GMFGRN: a matrix factorization and graph neural network approach for gene regulatory network inference. Briefings in Bioinformatics. 2024;25(2). doi:10.1093/bib/bbad529
BibTeX
@article{Li2024,
author = {Li, Shuo and Liu, Yan and Shen, Long-Chen and Yan, He and Song, Jiangning and Yu, Dong-Jun},
title = {GMFGRN: a matrix factorization and graph neural network approach for gene regulatory network inference},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {25},
number = {2},
doi = {10.1093/bib/bbad529}
}
EUVIMED